What Carna Health does
Carna Health provides an AI-driven enterprise platform, paired with point-of-care testing devices and native patient and clinician apps, to detect, manage, and prevent Cardio-Kidney-Metabolic disease at population scale. The cloud-based platform ingests data from devices, labs, and EHRs via FHIR/HL7/API interoperability to identify chronic kidney disease risk, predict progression, and deliver specialist-grade guidance to frontline providers. The company has a partnership with Siemens Healthineers combining Carna's digital platform with Siemens' point-of-care diagnostics infrastructure to broaden access to kidney screening. Carna Health was founded in 2021 and is headquartered in Boston.
Carna Health is a healthcare tool on Falcoscan. AI platform for chronic kidney disease screening and management. Falcoscan rates Carna Health with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Carna Health is founded in 2021, currently at Seed stage. Pricing: Paid.